Inhibition of Cyclic 3′,5′-AMP Phosphodiesterase in Islet Cells and Other Tissues by Tolbutamide
- 1 December 1971
- journal article
- Published by Springer Nature in Nature
- Vol. 234 (5327), 295-297
- https://doi.org/10.1038/234295a0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- CORRELATION OF PLASMA LEVELS OF ORAL ANTIDIABETIC AGENTS WITH BLOOD SUGAR RESPONSESAnnals of the New York Academy of Sciences, 2006
- Chlorpropamide and tolbutamide inhibition of adenosine 3′5′ cyclic monophosphate phosphodiesteraseBiochemical and Biophysical Research Communications, 1971
- Effect of Aminophylline on the Secretion of Insulin, Glucagon, Luteinizing Hormone and Growth Hormone in Humans1Journal of Clinical Endocrinology & Metabolism, 1970
- Inhibition of cyclic 3′,5′-nucleotide phosphodiesterase by phenothiazine and reserpine derivativesBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- A Possible Role for the Adenylcyclase System in Insulin Secretion*JCI Insight, 1967
- CHLORPROPAMIDE TREATMENT IN DIABETES INSIPIDUSThe Lancet, 1967
- An adrenergic receptor mechanism for the control of cyclic 3′5′ adenosine monophosphate synthesis in tissuesBiochemical and Biophysical Research Communications, 1967
- Stimulation of Insulin Secretion by TheophyllineNature, 1967
- Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitroBiochemical Journal, 1964
- Comparison of Plasma Insulin Levels Following Administration of Tolbutamide and GlucoseDiabetes, 1960